Senseonics Holdings Inc (SENS)
0.3227
+0.01
(+1.70%)
USD |
NYAM |
Nov 21, 16:00
0.322
0.00 (0.00%)
Pre-Market: 08:03
Senseonics Holdings Revenue (Quarterly): 4.263M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 4.263M |
| June 30, 2024 | 4.865M |
| March 31, 2024 | 5.047M |
| December 31, 2023 | 8.03M |
| September 30, 2023 | 6.097M |
| June 30, 2023 | 4.126M |
| March 31, 2023 | 4.137M |
| December 31, 2022 | 5.571M |
| September 30, 2022 | 4.622M |
| June 30, 2022 | 3.714M |
| March 31, 2022 | 2.481M |
| December 31, 2021 | 4.008M |
| September 30, 2021 | 3.532M |
| June 30, 2021 | 3.289M |
| March 31, 2021 | 2.846M |
| December 31, 2020 | 3.885M |
| September 30, 2020 | 0.767M |
| Date | Value |
|---|---|
| June 30, 2020 | 0.261M |
| March 31, 2020 | 0.036M |
| December 31, 2019 | 8.952M |
| September 30, 2019 | 4.319M |
| June 30, 2019 | 4.607M |
| March 31, 2019 | 3.423M |
| December 31, 2018 | 7.185M |
| September 30, 2018 | 5.158M |
| June 30, 2018 | 3.623M |
| March 31, 2018 | 2.946M |
| December 31, 2017 | 2.909M |
| September 30, 2017 | 2.097M |
| June 30, 2017 | 0.814M |
| March 31, 2017 | 0.553M |
| December 31, 2016 | 0.276M |
| September 30, 2016 | 0.037M |
| June 30, 2016 | 0.019M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.036M
Minimum
Mar 2020
8.952M
Maximum
Dec 2019
4.026M
Average
4.067M
Median
Revenue (Quarterly) Benchmarks
| Abbott Laboratories | 10.64B |
| DexCom Inc | 994.20M |
| Baxter International Inc | 2.699B |
| Boston Scientific Corp | 4.209B |
| Perspective Therapeutics Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.98M |
| Total Expenses (Quarterly) | 27.11M |
| EPS Diluted (Quarterly) | -0.04 |
| Enterprise Value | 170.58M |
| Gross Profit Margin (Quarterly) | -95.03% |
| Profit Margin (Quarterly) | -562.4% |
| Earnings Yield | -40.29% |
| Normalized Earnings Yield | -40.36 |